ArticleThe Journal of clinical investigation2023

Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models.

Xu Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.